AI identifies drug-resistant bacteria in two hours
A new microfluidic AI platform cuts bacterial resistance testing down to two hours, challenging the slow timelines of traditional lab cultures.
August 22, 2026
Follow us
latest articles
Discover the newest research about AI innovations in 🧪 Lab Medicine.
AI identifies superbugs using standard mass spectrometry
A new deep learning model bypasses slow genetic sequencing to identify dangerous bacterial strains in minutes, but instrument variation stands in the way of global deployment.
August 14, 2026
FDA Confronts Grail’s Failed Cancer Test Data
Regulators are forcing a public reckoning over whether marginal cancer screening benefits justify the risks of widespread adoption.
August 7, 2026
Machine Learning Fixes Liquid Biopsy False Alarms
A new machine learning model tackles the biological noise threatening to derail non-invasive cancer testing.
July 31, 2026
Large language models enable consensus-level interpretation in metagenomic diagnostics
A new study shows that local language models can analyze complex genomic data just as accurately as panels of medical experts.
July 31, 2026
The $450 Million Bet on Consumer Diagnostics
A massive new capital injection proves that venture capital is bypassing traditional doctors to sell health tracking directly to anxious consumers.
July 31, 2026
AI targets blood tests to find missed infections
Hospitals waste millions of blood culture tests on low-risk patients while missing critical infections, but a new machine learning model shows we can find more cases without running a single extra test.
July 20, 2026
Negative-Ion Mode MALDI-TOF MS Combined with Machine Learning for the Rapid Identification of Colistin-Resistant E. cloacae Complex
A new machine learning workflow cuts the detection time for superbugs from days to sixty minutes, shifting the battle against drug-resistant hospital infections.
June 14, 2026
AI predicts severe drug-induced liver injury without biopsies
A new machine learning model uses dual ultrasound measurements to identify severe liver damage, offering a way to bypass painful and risky biopsies.
June 10, 2026
Artificial intelligence-enabled coronary plaque quantification for personalized risk assessment and lipid-lowering therapy: Insights from the FISH&CHIPS study✰.
AI-Driven Coronary Plaque Analysis: 19.1% Risk Reduction in CAD with Targeted LDL-C Therapy 📉💔
April 21, 2026